In order to knock down expression of NRG1 in the MDA-MB 231 breast cancer cell line, we used the TRIPZ doxycycline-inducible vector [17] containing either short hairpin (sh)RNAs targeting the NRG1 gene or a control empty vector. This evidence concerns the gene NRG1 and breast cancer.